Min-Jeong Kim

Min-Jeong Kim (MD, PhD) is an Assistant Professor of Psychiatry and Behavioral Health at Stony Brook University's Renaissance School of Medicine. Her research bridges neuroimaging, neuroinflammation, and PET radioligand development to advance diagnostics and therapies for neurodegenerative and psychiatric disorders.

• Education:
  • PhD in Neuroscience (2011)
  • MS in Neuroscience (2005)
  • MD from Seoul National University College of Medicine (2001)

Her work focuses on neuroinflammation as a biomarker in conditions like Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, using PET imaging with novel radioligands (e.g., [(11)C]PS13, [(18)F]PS13). Recent publications highlight COX-1/COX-2 quantification, whole-body PET applications, and anti-inflammatory drug potency measurement.

Key awards include the 2021 Mitzi & William Blahd Pilot Research Grant (SNMMI), 2020 NIH Fellows Award, and 2019 Alavi-Mandell Award for PET radioligand research. She has contributed to studies on Alzheimer's disease, mild cognitive impairment, and neuroinflammatory pathways, with over 30 peer-reviewed publications.

Current research explores translational neuroimaging for drug development and neuroinflammatory mechanisms in dementia. She collaborates across institutions on clinical trials and radioligand validation, including applications in arthritis and neuromodulation for Alzheimer's disease.